» Articles » PMID: 38398060

6--Butoxy-10-nitro-12,13-dioxa-11-azatricyclo[7.3.1.0]trideca-2,4,6,10-tetraene Improves the X-ray Sensitivity on Inhibiting Proliferation and Promoting Oxidative Stress and Apoptosis of Oral Cancer Cells

Overview
Journal Biomedicines
Date 2024 Feb 24
PMID 38398060
Authors
Affiliations
Soon will be listed here.
Abstract

This in vitro study examines the anti-oral cancer effects and mechanisms of a combined X-ray/SK2 treatment, i.e., X-ray and 6--butoxy-10-nitro-12,13-dioxa-11-azatricyclo[7.3.1.0]trideca-2,4,6,10-tetraene (SK2). ATP cell viability and flow cytometry-based cell cycle, apoptosis, oxidative stress, and DNA damage assessments were conducted. The X-ray/SK2 treatment exhibited lower viability in oral cancer (Ca9-22 and CAL 27) cells than in normal (Smulow-Glickman, S-G) cells, i.e., 32.0%, 46.1% vs. 59.0%, which showed more antiproliferative changes than with X-ray or SK2 treatment. Oral cancer cells under X-ray/SK2 treatment showed slight subG1 and G2/M increments and induced high annexin V-monitored apoptosis compared to X-ray or SK2 treatment. The X-ray/SK2 treatment showed higher caspase 3 and 8 levels for oral cancer cells than other treatments. X-ray/SK2 showed a higher caspase 9 level in CAL 27 cells than other treatments, while Ca9-22 cells showed similar levels under X-ray and/or SK2. The X-ray/SK2 treatment showed higher reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP) depletion than other treatments. Meanwhile, the mitochondrial superoxide (MitoSOX) and glutathione levels in X-ray/SK2 treatment did not exhibit the highest rank compared to others. Moreover, oral cancer cells had higher γH2AX and/or 8-hydroxy-2-deoxyguanosine levels from X-ray/SK2 treatment than others. All these measurements for X-ray/SK2 in oral cancer cells were higher than in normal cells and attenuated by N-acetylcysteine. In conclusion, X-ray/SK2 treatment showed ROS-dependent enhanced antiproliferative, apoptotic, and DNA damage effects in oral cancer cells with a lower cytotoxic influence on normal cells.

References
1.
Zhang Y, Wu L, Wang Z, Wang J, Roychoudhury S, Tomasik B . Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic. Front Oncol. 2022; 12:838637. PMC: 9305609. DOI: 10.3389/fonc.2022.838637. View

2.
Cho H, Ahn K, Choi J, Hwang S, Kim W, Um H . Luteolin acts as a radiosensitizer in non‑small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade. Int J Oncol. 2015; 46(3):1149-58. DOI: 10.3892/ijo.2015.2831. View

3.
Aiguade J, Hao J, Forsyth C . Synthesis of a 2,9-dioxabicyclo[3.3.1]nonane via double intramolecular hetero-Michael addition: entry to the F-G ring system of the azaspiracids. Org Lett. 2001; 3(7):979-82. View

4.
El Amrani M, Lai D, Debbab A, Aly A, Siems K, Seidel C . Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum. J Nat Prod. 2013; 77(1):49-56. DOI: 10.1021/np4005745. View

5.
Wlodkowic D, Skommer J, Darzynkiewicz Z . Flow cytometry-based apoptosis detection. Methods Mol Biol. 2009; 559:19-32. PMC: 3863590. DOI: 10.1007/978-1-60327-017-5_2. View